Status:
COMPLETED
Trochanteric Bursal Repair After a Total Hip Replacement - Are There Benefits During the First 90 Days
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Bursa; Tuberculous
Hip Bursitis
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
During total hip arthroplasty surgery, the trochanteric bursa is routinely excised. This anatomical structure, which functions as a soft tissue barrier, is generally recommended for removal as it faci...
Detailed Description
During total hip arthroplasty surgery, the trochanteric bursa is routinely excised. This anatomical structure, which functions as a soft tissue barrier, is typically recommended for removal as it faci...
Eligibility Criteria
Inclusion
- Patients between 18 to 90 years of age
- With a diagnosis of primary hip osteoarthritis
- Willing to be included in the study
Exclusion
- Patients who had a known history of trochanteric bursitis, deep gluteal syndrome, sciatica, vertebral fracture, hip fracture, hip arthroscopy, and core decompression surgery
- Patients who had a history of bursal injection within 6 months
- Patients undergoing hip arthroplasty with a shortening osteotomy
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06553508
Start Date
January 1 2022
End Date
January 1 2023
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye), 06800